| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |